Pedro Exman
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
Papers in
- Oncology 14
- Global Cancer Incidence and Screening 3
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 3
- Cancer Risks and Factors 3
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 3
- Co-authors
- Sara Tolaney (7 shared papers)Nancy U. Lin (5 shared papers)Romualdo Barroso‐Sousa (4 shared papers)Eric P. Winer (3 shared papers)Joyce Lii (1 shared paper)José Roberto Filassi (1 shared paper)Heather Anne Parsons (2 shared papers)Marcelo Zugaib (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)World Journal of Oncology (1 paper)OncoTargets and Therapy (1 paper)Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesBrazilFrance
In The Last Decade
Pedro Exman
22 papers receiving 839 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 261
- Oncology 431
- Pulmonary and Respiratory Medicine 210
- Genetics 38
- Pathology and Forensic Medicine 45
Countries citing papers authored by Pedro Exman
This map shows the geographic impact of Pedro Exman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Exman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Exman more than expected).
Fields of papers citing papers by Pedro Exman
This network shows the impact of papers produced by Pedro Exman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Exman. The network helps show where Pedro Exman may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Exman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 155 | |
| 2 | 2020 | 146 | |
| 3 | 2020 | 117 | |
| 4 | 2019 | 99 | |
| 5 | 2021 | 78 | |
| 6 | 2018 | 70 | |
| 7 | HER2-positive metastatic breast cancer: a comprehensive review. | 2021 | 56 |
| 8 | 2019 | 39 | |
| 9 | 2019 | 34 | |
| 10 | 2021 | 17 | |
| 11 | 2013 | 16 | |
| 12 | 2022 | 10 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 4 | |
| 15 | 2020 | 3 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 2 | |
| 18 | Câncer de pele | 2015 | 1 |
| 19 | 2019 | 1 | |
| 20 | 2019 | 1 |
About Pedro Exman
Pedro Exman is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health, having authored 23 papers that have together received 859 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (3 papers), Global Cancer Incidence and Screening (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), PARP inhibition in cancer therapy (3 papers), Cancer Risks and Factors (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (261 citations), Oncology (431 citations), Pulmonary and Respiratory Medicine (210 citations), Genetics (38 citations) and Pathology and Forensic Medicine (45 citations). Pedro Exman has collaborated with scholars based in United States, Brazil and France. Frequent co-authors include Sara Tolaney, Nancy U. Lin, Romualdo Barroso‐Sousa, Eric P. Winer, Joyce Lii, José Roberto Filassi, Heather Anne Parsons, Marcelo Zugaib, Nancy Lynn Keating and Tracey Lynn O'Connor. Their work appears in journals such as Clinical Cancer Research, World Journal of Oncology, OncoTargets and Therapy, Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.